The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
The looming epidemic of diabetes-associated tuberculosis : learning lessons from HIV-associated tuberculosis. / Harries, A D; Lin, Y; Satyanarayana, S; Lönnroth, K; Li, L; Wilson, N; Chauhan, L S; Zachariah, R; Baker, M A; Jeon, C Y; Murray, M B; Maher, D; Bygbjerg, I C; Enarson, D A; Billo, N E; Kapur, A.
In: International Journal of Tuberculosis and Lung Disease, Vol. 15, No. 11, 2011, p. 1436-44, i.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The looming epidemic of diabetes-associated tuberculosis
T2 - learning lessons from HIV-associated tuberculosis
AU - Harries, A D
AU - Lin, Y
AU - Satyanarayana, S
AU - Lönnroth, K
AU - Li, L
AU - Wilson, N
AU - Chauhan, L S
AU - Zachariah, R
AU - Baker, M A
AU - Jeon, C Y
AU - Murray, M B
AU - Maher, D
AU - Bygbjerg, I C
AU - Enarson, D A
AU - Billo, N E
AU - Kapur, A
PY - 2011
Y1 - 2011
N2 - The prevalence of diabetes mellitus is increasing at a dramatic rate, and countries in Asia, particularly India and China, will bear the brunt of this epidemic. Persons with diabetes have a significantly increased risk of active tuberculosis (TB), which is two to three times higher than in persons without diabetes. In this article, we argue that the epidemiological interactions and the effects on clinical presentation and treatment resulting from the interaction between diabetes and TB are similar to those observed for human immunodeficiency virus (HIV) and TB. The lessons learned from approaches to reduce the dual burden of HIV and TB, and especially the modes of screening for the two diseases, can be adapted and applied to the screening, diagnosis, treatment and prevention of diabetes and TB. The new World Health Organization (WHO) and The Union Collaborative Framework for care and control of TB and diabetes has many similarities to the WHO Policy on Collaborative Activities to reduce the dual burden of TB and HIV, and aims to guide policy makers and implementers on how to move forward and combat this looming dual epidemic. The response to the growing HIV-associated TB epidemic in the 1980s and 1990s was slow and uncoordinated, despite clearly articulated warnings about the scale of the forthcoming problem. We must not make the same mistake with diabetes and TB. The Framework provides a template for action, and it is now up to donors, policy makers and implementers to apply the recommendations in the field and to 'learn by doing'.
AB - The prevalence of diabetes mellitus is increasing at a dramatic rate, and countries in Asia, particularly India and China, will bear the brunt of this epidemic. Persons with diabetes have a significantly increased risk of active tuberculosis (TB), which is two to three times higher than in persons without diabetes. In this article, we argue that the epidemiological interactions and the effects on clinical presentation and treatment resulting from the interaction between diabetes and TB are similar to those observed for human immunodeficiency virus (HIV) and TB. The lessons learned from approaches to reduce the dual burden of HIV and TB, and especially the modes of screening for the two diseases, can be adapted and applied to the screening, diagnosis, treatment and prevention of diabetes and TB. The new World Health Organization (WHO) and The Union Collaborative Framework for care and control of TB and diabetes has many similarities to the WHO Policy on Collaborative Activities to reduce the dual burden of TB and HIV, and aims to guide policy makers and implementers on how to move forward and combat this looming dual epidemic. The response to the growing HIV-associated TB epidemic in the 1980s and 1990s was slow and uncoordinated, despite clearly articulated warnings about the scale of the forthcoming problem. We must not make the same mistake with diabetes and TB. The Framework provides a template for action, and it is now up to donors, policy makers and implementers to apply the recommendations in the field and to 'learn by doing'.
KW - AIDS-Related Opportunistic Infections
KW - Antitubercular Agents
KW - Coinfection
KW - Cooperative Behavior
KW - Diabetes Complications
KW - Epidemics
KW - Health Policy
KW - Humans
KW - International Cooperation
KW - Mass Screening
KW - Prevalence
KW - Risk Factors
KW - Time Factors
KW - Tuberculosis
KW - World Health
U2 - 10.5588/ijtld.11.0503
DO - 10.5588/ijtld.11.0503
M3 - Journal article
C2 - 21902876
VL - 15
SP - 1436-44, i
JO - International Journal of Tuberculosis and Lung Disease
JF - International Journal of Tuberculosis and Lung Disease
SN - 1027-3719
IS - 11
ER -
ID: 38504417